IIA Grant

An IIA grant is a non-dilutive research and development grant from the Israel Innovation Authority, Israel's main public funder of private-sector tech R&D. Unlike venture capital, the IIA takes no equity and no board seat; instead, a recipient company repays the grant only if it commercializes successfully, through a royalty on product revenue, typically 3% to 5% annually plus interest at SOFR, with no obligation to repay at all if the funded R&D fails commercially.

What Are the Main IIA Grant Tracks?

The Tnufa track targets individual entrepreneurs or small teams at the idea stage, offering a conditional grant of up to NIS 200,000, with a ceiling as high as NIS 250,000, covering up to 80% to 85% of approved costs such as prototyping, patent filings and business development, and requiring no registered company to apply. The R&D Fund, the IIA's main track for operating companies, covers 20% to 50% of a project's R&D budget, with a higher match rate available for projects based in Israel's geographic periphery. The newer Startup Fund directly co-invests alongside private investors across financing rounds: a Pre-Seed program covering up to 60% of a round, capped at NIS 1.5 million within a NIS 2.5 million budget ceiling; a Seed program covering up to 50%, capped at NIS 5 million within a NIS 10 million ceiling; and a Round A program covering up to 30%, capped at NIS 15 million within a NIS 50 million ceiling.

What Obligations Come With an IIA Grant?

Royalty payments continue until 100% of the grant principal plus interest has been repaid from product revenue. Grant recipients also accept IP and technology-transfer restrictions: the company cannot sell, transfer or exclusively license grant-funded IP outside Israel without the IIA's prior written consent, and any change of control or acquisition requires IIA notification and approval, since a sale or relocation can trigger full repayment or an accelerated-royalty buyout. Grant funds must be used exclusively for the approved R&D program, and the IIA recognizes only specific approved costs, chiefly direct R&D labor, materials and limited overhead, leaving any unapproved expense the company's sole responsibility.

How Competitive Is IIA Funding?

Approval rates vary by program but generally run between 20% and 40% of applications. The IIA evaluates submissions against five factors: the technical novelty of the underlying invention, whether a viable economic rationale exists for pursuing the project in Israel, the applicant's capability to deliver and commercialize the technology, the degree of collaboration with partner organizations, and the clarity of the application itself.

Why Does the Royalty and IP Structure Matter Strategically?

IIA grants are the cheapest capital available to an Israeli startup, equity-free, failure-forgiving, and carrying a quality signal that can improve standing with later investors. But the same royalty and IP-relocation restrictions that make the grants low-risk for the state are a structural reason some Israeli companies eventually re-domicile their IP or headquarters outside Israel once they scale, since IIA consent requirements on cross-border IP transfer and change of control can complicate an international acquisition or a shift of core operations abroad.

Why It Matters

IIA grants function as the lowest-cost layer of Israeli startup capital, but the royalty and IP strings attached are also a structural reason some Israeli companies eventually re-domicile outside Israel.